Three-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)

被引：0

作者：

Felip Font, E. ^{[1
]}

Gettinger, S. N. ^{[2
]}

Burgio, M. A. ^{[3
]}

Antonia, S. J. ^{[4
]}

Holgado, E. ^{[5
]}

Spigel, D. R. ^{[6
]}

Arrieta, O. ^{[7
]}

Domine Gomez, M. ^{[8
]}

Aren Frontera, O. ^{[9
]}

Brahmer, J. ^{[10
]}

Chow, L. Q. ^{[11
]}

Crino, L. ^{[12
]}

Butts, C. ^{[13
]}

Coudert, B. ^{[14
]}

Horn, L. ^{[15
]}

Steins, M. ^{[16
]}

Geese, W. J. ^{[17
]}

Li, A. ^{[17
]}

Healey, D. ^{[17
]}

Vokes, E. E. ^{[18
]}

机构：

[1] Hosp Univ Vall dHebron, Thorac Tumors Grp, Barcelona, Spain

[2] Yale Canc Ctr, Oncol, New Haven, CT 06510 USA

[3] IRCCS Ist Sci Romagnolo Studio & Cura Tumori, Oncol, Meldola, Italy

[4] H Lee Moffitt Canc Ctr & Res Inst, Oncol, Tampa, FL USA

[5] Hosp Madrid, Oncol, Norte Sanchinarro, Madrid, Spain

[6] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Med Oncol, Nashville, TN 37203 USA

[7] Inst Nacl Cancerol, Oncol, Mexico City, DF, Mexico

[8] Fdn Jimenez Diaz, Oncol, Madrid, Spain

[9] Ctr Int Estudios Clin, Oncol, Santiago, Chile

[10] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Oncol, Baltimore, MD 21231 USA

[11] Univ Washington, Oncol, Seattle, WA 98195 USA

[12] Osped Perugia, Oncol, Perugia, Italy

[13] Cross Canc Inst, Oncol, Edmonton, AB, Canada

[14] Ctr Georges Francois Leclerc, Oncol, Dijon, France

[15] Vanderbilt Ingram Canc Ctr, Thorac Oncol, Nashville, TN 37232 USA

[16] Heidelberg Univ Hosp, Thoraxklin, Oncol, Heidelberg, Germany

[17] Bristol Myers Squibb, Immunooncol, Princeton, NJ 08540 USA

[18] Univ Chicago Med & Biol Sci, Oncol, Chicago, IL 60637 USA

来源：

ANNALS OF ONCOLOGY | 2017年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1301PD

引用

页数：1

共 50 条

[41] Frequency of follow-up brain imaging in non-small cell lung cancer (NSCLC) patients with previously treated brain metastases (BrMs)
Milner-Watts, C.
Perna, M.
O'Brien, M.
LUNG CANCER, 2020, 139 : S20 - S20
[42] Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
Martinez Moreno, E.
Irigoyen Medina, A.
Martinez Barroso, K.
Borregon Rivilla, M.
Alvarez Cabellos, R.
Cardenas, J. D.
Andrade Santiago, J.
Burgueno Lorenzo, I.
Trujillo Alba, B.
Chacon Lopez-Muniz, J. I.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2430 - S2430
[43] Nivolumab in Second Line Non-Small Cell Lung Cancer - Comparing Real-World Outcomes in England to CheckMate (CM) 017 and 057
Popat, S.
Tanna, N.
Hartridge-Lambert, S.
Kiff, C.
Sowdani, A.
Rothwell, B.
Henrik-Brodtkorb, T.
Ling, C.
Smittenaar, R.
Bomb, M.
Turnbull, A.
Lawton, S.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S637 - S638
[44] Three-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of ONO-4538-05 and ONO-4538-06 studies
Horinouchi, Hidehito
Nishio, Makoto
Hida, Toyoaki
Nakagawa, Kazuhiko
Sakai, Hiroshi
Nogami, Naoyuki
Atagi, Shinji
Takahashi, Toshiaki
Saka, Hideo
Takenoyama, Mitsuhiro
Katakami, Nobuyuki
Tanaka, Hiroshi
Takeda, Koji
Satouchi, Miyako
Isobe, Hiroshi
Maemondo, Makoto
Goto, Koichi
Hirashima, Tomonori
Minato, Koichi
Sumiyoshi, Naoki
Tamura, Tomohide
CANCER MEDICINE, 2019, 8 (11): : 5183 - 5193
[45] Monotherapy with docetaxel in previously treated patients with advanced non-small cell lung carcinoma
Courousis, C
Androulakis, N
Heras, P
Vamvakas, I
Metaxaris, G
Souklakos, J
Vlastos, F
Dimadi, M
Vossos, A
Aravosita, P
Georgopoulou, T
Papandreou, A
Hatzidaki, D
Papadakis, E
Georgoulias, V
2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 571 - 574
[46] Five-year follow-up from the CA209-003 study of nivolumab in previously treated advanced non-small cell lung cancer (NSCLC): Clinical characteristics of long-term survivors
Brahmer, Julie
Horn, Leora
Jackman, David
Spigel, David
Antonia, Scott
Hellmann, Matthew
Powderly, John
Heist, Rebecca
Sequist, Lecia
Smith, David C.
Leming, Philip
Geese, William J.
Yoon, Dennis
Li, Ang
Gettinger, Scott
CANCER RESEARCH, 2017, 77
[47] Nivolumab monotherapy in patients with previously treated advanced non-small cell lung cancer (NSCLC) in routine clinical practice in a Spanish center
Mielgo, X.
Toro, P.
Ruiz-Gimenez, L.
Olier, C.
Perez, M.
Rosero, A.
Camara, J. C.
Hernando, S.
Hurtado, A.
Jara, C.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S135
[48] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Dragnev, K. H.
Seltzer, M.
Rigas, J. R.
DiSalvo, W. M.
Simeone, S.
Johnstone, D.
Nugent, W.
Waxman, S.
Dmitrovsky, E.
ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
[49] Longer-Term Follow-Up of a Phase 2 Study (CheckMate 063) of Nivolumab in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
Horn, Leora
Rizvi, Naiyer A.
Mazieres, Julien
Planchard, David
Stinchcombe, Thomas E.
Dy, Grace K.
Antonia, Scott J.
Lena, Herve
Minenza, Elisa
Mennecier, Bertrand
Otterson, Gregory A.
Campos, Luis T.
Gandara, David R.
Levy, Benjamin P.
Nair, Suresh G.
Zalcman, Gerard
Wolf, Juergen
Paik, Paul
Li, Ang
Xu, Dong
Neely, Jaclyn
Qi, Zhenhao
Harbison, Christopher
Lynch, Mark
Ramalingam, Suresh S.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S175 - S176
[50] Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153
Waterhouse, David M.
Garon, Edward B.
Chandler, Jason
McCleod, Michael
Hussein, Maen
Jotte, Robert
Horn, Leora
Daniel, Davey B.
Keogh, George
Creelan, Ben
Einhorn, Lawrence H.
Baker, Justin
Kasbari, Samer
Nikolinakos, Petros
Babu, Sunil
Couture, Felix
Leighl, Natasha B.
Reynolds, Craig
Blumenschein, George, Jr.
Gunuganti, Vijay
Li, Ang
Aanur, Nivedita
Spigel, David R.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (33) : 3863 - 3873

← 1 2 3 4 5 →